New Key Statistics Module, Z-Score and F-Score
NYSE:WST Key Ratios
Market Cap $ M | 28,237.51 |
Enterprise Value $ M | 27,692.61 |
P/E(ttm) | 48.95 |
PE Ratio without NRI | 47.74 |
Forward PE Ratio | 50.51 |
Price/Book | 9.84 |
Price/Sales | 9.84 |
Price/Free Cash Flow | 69.95 |
Price/Owner Earnings | 56.40 |
Payout Ratio % | 0.10 |
Revenue (TTM) $ M | 2,949.00 |
EPS (TTM) $ | 7.88 |
Beneish M-Score | -2.71 |
10-y EBITDA Growth Rate % | 15.00 |
5-y EBITDA Growth Rate % | 22.00 |
y-y EBITDA Growth Rate % | 5.10 |
EV-to-EBIT | 39.17 |
EV-to-EBITDA | 32.80 |
PEG | 2.17 |
Shares Outstanding M | 73.21 |
Net Margin (%) | 20.12 |
Operating Margin % | 23.98 |
Pre-tax Margin (%) | 23.66 |
Quick Ratio | 2.24 |
Current Ratio | 2.88 |
ROA % (ttm) | 15.96 |
ROE % (ttm) | 21.26 |
ROIC % (ttm) | 23.46 |
Dividend Yield % | 0.20 |
Altman Z-Score | 20.93 |
WST Number of Guru Trades
WST Volume of Guru Trades
Gurus Latest Trades with NYSE:WST
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:WST is held by these investors
Total 4
West Pharmaceutical Services Inc Insider Transactions
No Available Data
News about NYSE:WST
Total 0- 1